Oxygen Therapy Market Size, Share and Trends 2026 to 2035

According to MarketnReports, the global Oxygen Therapy Market size was estimated at USD 38.9 billion in 2025 and is expected to reach USD 75.3 billion by 2035, growing at a CAGR of 6.8% from 2026 to 2035. Oxygen Therapy Market is driven by increasing incidence of chronic respiratory diseases and rising demand for home healthcare.

What are the Key Insights of the Oxygen Therapy Market?

  • Market value estimated at USD 38.9 billion in 2025, projected to reach USD 75.3 billion by 2035.
  • Compound annual growth rate (CAGR) of 6.8% during the forecast period from 2026 to 2035.
  • Market is driven by increasing prevalence of respiratory diseases and growing adoption of home-based oxygen therapy.
  • Oxygen source equipment subsegment dominates the product segment with 63% share due to its critical role in oxygen generation and storage.
  • COPD subsegment dominates the application segment with 40% share as it affects millions globally and requires long-term oxygen support.
  • Home healthcare subsegment dominates the end-use segment with 55% share owing to the shift towards patient-centric care and reduced hospital stays.
  • North America dominates with 35% market share because of advanced healthcare infrastructure, high disease prevalence, and favorable reimbursement policies.

What is the Oxygen Therapy Market Industry Overview?

The Oxygen Therapy Market encompasses medical devices and systems designed to deliver supplemental oxygen to patients with respiratory deficiencies, aiding in the management of conditions where blood oxygen levels are inadequate, such as chronic obstructive pulmonary disease, asthma, and pneumonia. This market includes oxygen source equipment like concentrators and cylinders, as well as delivery devices such as masks and cannulas, which ensure precise and efficient oxygen administration in both clinical and home settings. Market definition refers to the comprehensive ecosystem of technologies, accessories, and services that facilitate oxygen supplementation to improve patient oxygenation, reduce hypoxia-related complications, and enhance quality of life, driven by advancements in portable and user-friendly solutions that support ambulatory care and long-term therapy.

What are the Market Dynamics of the Oxygen Therapy Market?

Growth Drivers

The growth drivers of the Oxygen Therapy Market are significantly influenced by the escalating global burden of chronic respiratory conditions, including COPD and asthma, which affect hundreds of millions worldwide and necessitate reliable oxygen supplementation to manage symptoms and prevent exacerbations. Technological innovations, such as portable oxygen concentrators with extended battery life and lightweight designs, have enhanced patient mobility and compliance, particularly in home care settings, while the integration of smart features like remote monitoring via IoT enables proactive healthcare management. Furthermore, the aging population, projected to double by 2050 according to WHO, amplifies demand for long-term oxygen therapy, supported by expanding healthcare access in emerging economies and government initiatives promoting home-based care to alleviate hospital overcrowding.

Restraints

Restraints in the Oxygen Therapy Market stem from the high costs of advanced devices and ongoing maintenance, which can limit accessibility in low-income regions and for uninsured patients, exacerbating disparities in respiratory care. Regulatory hurdles, including stringent FDA approvals and compliance with safety standards, delay product launches and increase development expenses for manufacturers. Additionally, potential side effects like oxygen toxicity and nasal irritation from prolonged use deter some patients, while supply chain vulnerabilities, highlighted during the COVID-19 pandemic, disrupt the availability of critical components like semiconductors and medical-grade oxygen.

Opportunities

Opportunities in the Oxygen Therapy Market are emerging from the rapid adoption of telehealth and remote patient monitoring technologies, which allow for real-time data tracking and personalized therapy adjustments, opening avenues for integrated digital health solutions in chronic disease management. The expansion into untapped markets in Asia Pacific and Latin America, driven by rising healthcare investments and urbanization, presents growth potential through localized manufacturing and partnerships with regional distributors. Moreover, advancements in sustainable and energy-efficient devices, such as solar-powered concentrators for remote areas, align with global environmental goals and address the needs of underserved populations, fostering innovation and market diversification.

Challenges

Challenges facing the Oxygen Therapy Market include ensuring device safety and efficacy amid rising cyber threats to connected medical equipment, requiring robust security protocols to protect patient data and prevent malfunctions. The lack of standardized reimbursement policies across regions creates financial barriers for patients, particularly in developing countries where out-of-pocket expenses dominate. Additionally, the need for skilled healthcare professionals to train users on proper device operation and maintenance poses logistical issues, while environmental concerns over the carbon footprint of oxygen production and disposal of single-use accessories demand sustainable practices to maintain long-term market viability.

Oxygen Therapy Market: Report Scope

Report Attributes Report Details
Report Name Oxygen Therapy Market
Market Size 2025 USD 38.9 Billion
Market Forecast 2035 USD 75.3 Billion
Growth Rate CAGR of 6.8%
Report Pages 220
Key Companies Covered

Inogen, Inc., ResMed Inc., Philips Respironics, Invacare Corporation, Fisher & Paykel Healthcare Limited, Chart Industries, Inc., Linde plc, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, DeVilbiss Healthcare, and Others.
Segments Covered By Product, By Application, By End-Use, and By Region.
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, and The Middle East and Africa (MEA)
Base Year 2025
Historical Year 2020 - 2024
Forecast Year 2026 - 2035
Customization Scope Avail customized purchase options to meet your exact research needs.

What is the Market Segmentation of the Oxygen Therapy Market?

The Oxygen Therapy Market is segmented by product, application, end-use, and region.

By Product Segment, oxygen source equipment emerges as the most dominant subsegment, holding approximately 63% share, followed by oxygen delivery devices at 37%. Oxygen source equipment dominates due to its essential function in providing a reliable supply of oxygen through concentrators and liquid systems, driving the market by enabling scalable solutions for both acute and chronic care, which reduces dependency on hospital visits and supports the growing trend of home-based therapy amid rising respiratory disease prevalence.

By Application Segment, COPD leads as the most dominant subsegment with 40% share, while sleep apnea ranks second at 20%. COPD dominates because of its high global incidence, affecting over 300 million people and being a leading cause of mortality, propelling market growth through the demand for long-term oxygen therapy that improves survival rates, enhances quality of life, and integrates with multidisciplinary care approaches to manage exacerbations effectively.

By End-Use Segment, home healthcare stands out as the most dominant subsegment, capturing 55% share, with hospitals as the second at 30%. Home healthcare dominates owing to the preference for cost-effective, convenient treatment options that minimize hospital admissions and empower patients with portable devices, fueling market expansion by aligning with aging demographics and policy shifts towards decentralized healthcare delivery.

What are the Recent Developments in the Oxygen Therapy Market?

  • In June 2025, Inogen, Inc. launched the VoxiTM 5, a new stationary oxygen concentrator designed to improve access to high-quality oxygen therapy for long-term care patients in the United States, expanding its portfolio and leveraging existing sales channels.
  • In July 2025, VARON introduced the VP-8G portable oxygen concentrator, noted as the lightest and most advanced model to date, aimed at enhancing mobility and convenience for users requiring on-the-go therapy.
  • In January 2025, Caire announced the launch of its IntenOxy 5 stationary oxygen concentrator, now available in the United States and Puerto Rico, with plans for expansion to Canada, focusing on efficient power consumption and high oxygen concentration.

What is the Regional Analysis of the Oxygen Therapy Market?

North America to dominate the global market.

North America holds the dominant position in the Oxygen Therapy Market, accounting for about 35% share, with the United States as the leading country due to its sophisticated healthcare system, substantial R&D investments, high prevalence of respiratory diseases like COPD affecting millions, and supportive policies such as Medicare reimbursements that facilitate widespread adoption of advanced devices.

Asia Pacific is experiencing the fastest growth, driven by increasing healthcare expenditure, rising pollution levels, and an aging population, with China dominating through its massive patient base, government initiatives for respiratory health, and local manufacturing of affordable concentrators to meet surging demand from urban and rural areas.

Europe maintains a strong presence, emphasizing innovative therapies and regulatory compliance, with Germany as the key contributor owing to its advanced medical infrastructure, high COPD incidence, and EU-wide reimbursement schemes that promote home care solutions and technological integrations like smart monitoring.

Latin America shows emerging potential, fueled by improving healthcare access and rising awareness of respiratory conditions, led by Brazil with investments in hospital expansions and public health programs targeting asthma and pneumonia, though economic disparities challenge uniform market penetration.

The Middle East and Africa region is nascent but growing, with the UAE dominating through healthcare diversification efforts, luxury medical facilities, and initiatives for chronic disease management, leveraging oil revenues to import cutting-edge equipment and train professionals for enhanced patient outcomes.

Who are the Key Market Players and Strategies in the Oxygen Therapy Market?

Inogen, Inc. focuses on portable oxygen concentrators with FDA clearances and EU certifications, employing acquisitions and product launches to expand its respiratory portfolio and target home care markets for enhanced patient mobility.

ResMed Inc. prioritizes sleep apnea solutions like CPAP devices, investing in smart technologies for remote monitoring and partnerships to integrate AI for personalized therapy, aiming to dominate the growing OSA segment.

Philips Respironics develops IoT-enabled concentrators and masks, adopting voluntary corrections and price reductions to ensure safety and accessibility, while expanding in emerging markets through local adaptations.

Invacare Corporation specializes in home oxygen systems, pursuing acquisitions by firms like React Health to broaden distribution and innovate in stationary devices for long-term care.

Fisher & Paykel Healthcare Limited innovates nasal masks and humidification systems, launching silicone-free products to improve comfort, and focusing on R&D for energy-efficient solutions in hospital and home settings.

Chart Industries, Inc. emphasizes liquid oxygen devices and acquisitions like CAIRE to enhance manufacturing capabilities, targeting industrial and medical applications with sustainable, high-purity oxygen technologies.

Linde plc leverages gas supply expertise for oxygen cylinders and concentrators, forming UNICEF partnerships for low-resource areas and investing in robust designs to address global oxygen shortages.

Drägerwerk AG & Co. KGaA provides advanced ventilation-integrated oxygen therapy, emphasizing safety standards and collaborations for clinical trials to advance hyperbaric and topical wound solutions.

Teleflex Incorporated offers delivery devices like cannulas and masks, focusing on ergonomic designs and M&A to integrate complementary technologies for emergency and ambulatory care.

DeVilbiss Healthcare launches high-capacity concentrators like the 1060AW, prioritizing durability and quiet operation through global distribution agreements to capture the portable segment.

What are the Market Trends in the Oxygen Therapy Market?

  • Increasing adoption of portable oxygen concentrators for enhanced patient mobility and home care.
  • Integration of IoT and AI for remote monitoring and personalized therapy adjustments.
  • Rise in demand for energy-efficient and sustainable oxygen generation technologies.
  • Expansion of hyperbaric oxygen therapy applications in wound healing and neurology.
  • Growing preference for non-invasive delivery devices like nasal cannulas for comfort.
  • Surge in mergers and acquisitions to consolidate market presence and innovate products.
  • Focus on regulatory compliance and FDA clearances for new device launches.

What Market Segments and their Subsegments are Covered in the Oxygen Therapy Market Report?

By Product

  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • Oxygen Cylinders
  • PAP Devices
  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-Rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others

By Application

  • COPD
  • Asthma
  • Cystic Fibrosis
  • Respiratory Distress Syndrome
  • Pneumonia
  • Sleep Apnea
  • Heart Failure
  • Lung Cancer
  • Acute Respiratory Infections
  • Other Respiratory Diseases
  • Others

By End-Use

  • Home Healthcare
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Emergency Medical Services
  • Nursing Homes
  • Rehabilitation Centers
  • Diagnostic Centers
  • Long-Term Care Facilities
  • Other Healthcare Facilities
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

The Oxygen Therapy Market involves devices and systems for delivering supplemental oxygen to patients with low blood oxygen levels, including source equipment and delivery tools for managing respiratory conditions.

Key factors include rising chronic respiratory diseases, technological advancements in portable devices, aging populations, increasing home healthcare demand, and supportive government initiatives.

The market is projected to grow from approximately USD 38.9 billion in 2026 to USD 75.3 billion by 2035.

The CAGR is expected to be 6.8% from 2026 to 2035.

North America will contribute notably, holding around 35% of the market value due to advanced infrastructure and high disease prevalence.

Major players include Inogen, Inc., ResMed Inc., Philips Respironics, Invacare Corporation, Fisher & Paykel Healthcare Limited, Chart Industries, Inc., Linde plc, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, and DeVilbiss Healthcare.

The report provides comprehensive analysis including market size, trends, segmentation, key players, regional insights, and forecasts from 2026 to 2035.

Stages include raw material sourcing, device manufacturing and assembly, quality testing and certification, distribution and sales, end-user training, and after-sales service with maintenance.

Trends are shifting towards portable, smart devices with IoT integration, while consumers prefer user-friendly, comfortable solutions for home use that enhance mobility and adherence.

Factors include FDA approvals for safety, reimbursement policies expanding access, and environmental pushes for energy-efficient devices to reduce carbon emissions from manufacturing.